216 related articles for article (PubMed ID: 18072496)
21. Feasibility of interstitial diffuse optical tomography using cylindrical diffusing fibers for prostate PDT.
Liang X; Wang KK; Zhu TC
Phys Med Biol; 2013 May; 58(10):3461-80. PubMed ID: 23629149
[TBL] [Abstract][Full Text] [Related]
22. Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy.
Jankun J; Lilge L; Douplik A; Keck RW; Pestka M; Szkudlarek M; Stevens PJ; Lee RJ; Selman SH
J Urol; 2004 Aug; 172(2):739-43. PubMed ID: 15247773
[TBL] [Abstract][Full Text] [Related]
23. Dosimetry estimation on variations of patient size in prostate volumetric-modulated arc therapy.
Chow JC; Jiang R
Med Dosim; 2013; 38(1):42-7. PubMed ID: 22819685
[TBL] [Abstract][Full Text] [Related]
24. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities.
Weersink RA; Bogaards A; Gertner M; Davidson SR; Zhang K; Netchev G; Trachtenberg J; Wilson BC
J Photochem Photobiol B; 2005 Jun; 79(3):211-22. PubMed ID: 15896648
[TBL] [Abstract][Full Text] [Related]
25. Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer.
Du KL; Mick R; Busch TM; Zhu TC; Finlay JC; Yu G; Yodh AG; Malkowicz SB; Smith D; Whittington R; Stripp D; Hahn SM
Lasers Surg Med; 2006 Jun; 38(5):427-34. PubMed ID: 16788929
[TBL] [Abstract][Full Text] [Related]
26. Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate.
Li J; Altschuler MD; Hahn SM; Zhu TC
Phys Med Biol; 2008 Aug; 53(15):4107-21. PubMed ID: 18612172
[TBL] [Abstract][Full Text] [Related]
27. Illumination profile characterization of a light device for the dosimetry of intra-pleural photodynamic therapy for mesothelioma.
Munck C; Mordon S; Betrouni N
Photodiagnosis Photodyn Ther; 2016 Dec; 16():23-26. PubMed ID: 27594672
[TBL] [Abstract][Full Text] [Related]
28. Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate.
Rendon A; Beck JC; Lilge L
Phys Med Biol; 2008 Feb; 53(4):1131-49. PubMed ID: 18263963
[TBL] [Abstract][Full Text] [Related]
29. A dose delivery verification method for conventional and intensity-modulated radiation therapy using measured field fluence distributions.
Renner WD; Sarfaraz M; Earl MA; Yu CX
Med Phys; 2003 Nov; 30(11):2996-3005. PubMed ID: 14655947
[TBL] [Abstract][Full Text] [Related]
30. A new finite element approach for near real-time simulation of light propagation in locally advanced head and neck tumors.
Oakley E; Wrazen B; Bellnier DA; Syed Y; Arshad H; Shafirstein G
Lasers Surg Med; 2015 Jan; 47(1):60-7. PubMed ID: 25559426
[TBL] [Abstract][Full Text] [Related]
31. Photobleaching-based method to individualize irradiation time during interstitial 5-aminolevulinic acid photodynamic therapy.
Hennig G; Stepp H; Johansson A
Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):275-81. PubMed ID: 21864802
[TBL] [Abstract][Full Text] [Related]
32. Biological dose volume histograms during conformal hypofractionated accelerated radiotherapy for prostate cancer.
Koukourakis MI; Abatzoglou I; Touloupidis S; Manavis I
Med Phys; 2007 Jan; 34(1):76-80. PubMed ID: 17278492
[TBL] [Abstract][Full Text] [Related]
33. Strategies for automatic online treatment plan reoptimization using clinical treatment planning system: a planning parameters study.
Li T; Wu Q; Zhang Y; Vergalasova I; Lee WR; Yin FF; Wu QJ
Med Phys; 2013 Nov; 40(11):111711. PubMed ID: 24320419
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy of prostate cancer with multileaf collimators (MLCs) optimization of the undulating dose distribution at the MLC edge.
Koelbl O; Schwab F; Bratengeier K; Vordermark D; Flentje M
Strahlenther Onkol; 2005 Feb; 181(2):108-12. PubMed ID: 15702299
[TBL] [Abstract][Full Text] [Related]
35. In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland.
Lee LK; Whitehurst C; Pantelides ML; Moore JV
Photochem Photobiol; 1995 Nov; 62(5):882-6. PubMed ID: 8570727
[TBL] [Abstract][Full Text] [Related]
36. Parallelized Monte-Carlo dosimetry using graphics processing units to model cylindrical diffusers used in photodynamic therapy: From implementation to validation.
Dupont C; Baert G; Mordon S; Vermandel M
Photodiagnosis Photodyn Ther; 2019 Jun; 26():351-360. PubMed ID: 31039411
[TBL] [Abstract][Full Text] [Related]
37. Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques.
Jacob D; Raben A; Sarkar A; Grimm J; Simpson L
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):820-7. PubMed ID: 18455325
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
39. The role of photodynamic therapy (PDT) physics.
Zhu TC; Finlay JC
Med Phys; 2008 Jul; 35(7):3127-36. PubMed ID: 18697538
[TBL] [Abstract][Full Text] [Related]
40. Dose verification of an IMRT treatment planning system with the BEAM EGS4-based Monte Carlo code.
Francescon P; Cora S; Chiovati P
Med Phys; 2003 Feb; 30(2):144-57. PubMed ID: 12607832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
